Year 2019 Vol. 27 No 2




Omsk State Medical University 1,
Omsk Regional Clinical Medical Sanitary Unit 9 2, Omsk,
The Russian Federation

Objective. To work out and to test experimentally the method for modeling gastric ulcer in small laboratory animals.
Methods. The experiment included 38 white mongrel rats. Mini-laparotomy was performed, stomach was taken out into the operating field. 70% solution of the acetic acid was introduced into the submucosal layer from the side of the stomach lumen using the device for intra-organ intraluminal injections. The animals were excluded from the experiment on the 3rd, 5th, 7th day after the operation, the area of ulcerative defect with microscopic assessment of tissue and cellular composition in the area of ulcerative defect was determined.
Results. In two animals, when injected into the submucosal layer of the stomach wall 0.06 ml of 70% acetic acid, there was a total necrosis of all layers with concurrent phlegmon of the stomach; they died on the 2nd day because of the generalized peritonitis on the background of perforation of the stomach necrotic wall. The median area of gastric ulcer was: with the introduction of 0.04 ml after 3 days 1.88 cm2, after 7 days 0.34 cm2; with the introduction of 0.03 ml 0.94 cm2 and 0.19 cm2, respectively; with the introduction of 0.02 ml 0.63 cm2 and 0.16 cm2, respectively; with the introduction of 0.01 ml 0.31 cm2 and 0.02 cm2, respectively. It is morphologically confirmed that the bottom of the ulcer is the muscle layer of the stomach. Thus, the threshold dose of the injected 70% acid solution (0.06 ml) was revealed, the excess of which results in total necrosis of the stomach wall, as well as the prospects for a possible relationship between the volume of the damaging factor, the size of the emerging ulcer defect and the healing time of the latter.
Conclusions. The proposed method of modeling gastric ulcers is reproducible and can be recommended for use in experimental surgery.

Keywords: gastric ulcer, experimental modeling, acetic acid, rats, intraluminal injection, mini-laparotomy
p. 131-137 of the original issue
  1. Brzozowski T. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment- Polish achievements. J Physiol Pharmacol. 2003 Dec;54(Suppl 3):99-126.
  2. Agbaje EO, Doe YP. Gastric and duodenal antiulcer effects of aqueous bark extract of Dialium guineense Wild. (Fabaceae) and the possible mechanisms in laboratory models. J Phytopharmacol. 2015;4(5):268-75.
  3. Bahadır FE, Özbeyli D, Mardinoğlu G, Ozbeyli D, Temiz F, M. Sağanak, H. Şahin, M. Yüksel, F.Ercan, B. Yeğen. Regular swimming before the induction of ulcer ameliorates oxidative gastric damage in rats: the anxiolytic effect of exercise. MMJ. 2016;29(3):135-44. doi: 10.5472/MMJoa.2903.01
  4. Manjegowda SB, Rajagopal HM, Dharmesh SM. Polysaccharide of Black cumin (Nigella sativa) modulates molecular signaling cascade of gastric ulcer pathogenesis. Int J Biol Macromol. 2017 Aug;101:823-36. doi: 10.1016/j.ijbiomac.2017.03.093
  5. de Oliveira Cabral C, Campos A, da Silva LM, Boeing T, de Andrade SF, Filho VC, Nesello LÂN. Gastroprotective potential of methanolic extract and dimethyl cardamonin from Campomanesia reitziana fruits in mice. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jun;390(6):661-66. doi: 10.1007/s00210-017-1369-0
  6. Okabe S, Amagase K. An overview of acetic acid ulcer models-the history and state of the art of peptic ulcer research. Biol Pharm Bull. 2005 Aug;28(8):1321-41. doi: 10.1248/bpb.28.1321
  7. Lutsenko VD, Migunov AA, Tatyanenko TN, Suchalkin EB, Gontarev SN. Application of biopolymeric materials at hollow organ perforation in experiment. Novosti Khirurgii. 2013;21(4):10-15. doi: 10.18484/2305-0047.2013.4.10 (in Russ.)
  8. Berenguer B, Sánchez LM, Quílez A, López-Barreiro M, de Haro O, Gálvez J, Martín MJ. Protective and antioxidant effects of Rhizophora mangle L. against NSAID-induced gastric ulcers. J Ethnopharmacol. 2006 Jan 16;103(2):194-200. doi: 10.1016/j.jep.2005.08.029
  9. Oh TY, Ahn GJ, Choi SM, Ahn BO, Kim WB. Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract. World J Gastroenterol. 2005 Dec 21;11(47):7450-56. doi: 10.3748/wjg.v11.i47.7450
  10. Soni H, Shah A, Paul A, Patel G. Anti-ulcer activity of herbo-mineral formulation (Asecure capsule) against experimentally induced acute and chronic gastric ulcers in rats. Int J Pharmacol Clin Sci. 2014 Sep;3(Is):61-67.
Address for correspondence:
644043, The Russian Federation,
Omsk, Lenin Str., 12,
Omsk State Medical University,
Department of Faculty Surgery, Urology.
Tel.: +7 3812 35-91-30,
Vyacheslav N. Nikitin
Information about the authors:
Nikitin Vyacheslav N., PhD, Associate Professor of the Department of Faculty Surgery, Urology, Omsk State Medical University, Omsk, Russian Federation.
Poluektov Vladimir L., MD, Professor, Head of the Department of Faculty Surgery, Urology, Omsk State Medical University, Omsk, Russian Federation.
Khramykh Tatyana P., MD, Professor, Head of the Department of Topographic Anatomy and Operative Surgery, Omsk State Medical University, Omsk, Russian Federation.
Barskaya Lyubov O., Assistant of the Department of Topographic Anatomy and Operative Surgery, Omsk State Medical University, Omsk, Russian Federation.
Zablotskaia Elena A., Morbid Anatomist, Omsk Regional Clinical Medical Sanitary Unit 9, Omsk, Russian Federation.
Putintsev Vladislav A., 5-Year Medical Student, Omsk State Medical University, Omsk, Russian Federation.
Efanov Vladimir P., 5-Year Medical Student, Omsk State Medical University, Omsk, Russian Federation.




Sumy State University, Medical institute, Sumy,

Objective. To improve treatment effectiveness in patients with multi-drug-resistant pulmonary tuberculosis, the spread of the lesion in which exceeds 5 segments, by introducing an improved combined method of treatment into practice.
Methods. The proposed method of surgical treatment was used in 17 patients with the extensive multi-drug-resistant pulmonary tuberculosis. Extended resistance was found in 6 (35.3%) people, multi-drug resistance  in 11 (64.7%). The first stage of the proposed technique was the application of the pneumoperitoneum 2 months before the operation. A modified thoracoplasty was used during the surgical intervention. The operation implied a complete removal of the I rib, the partial cutting of the paravertebral segments II and IV (46 cm), V and VII (68 cm) ribs and fragmentation of the III and VI ribs by snacking them in the vertebral and axillary divisions, after which the vertebral portions II and IV, V and VII ribs were taken together over the fragmented sections of III and VI ribs, which significantly reduced the volume of the pleural cavity and decreased the collapse of the affected lung.
Results. The postoperative bed-day was 75.838.3. Closure of the decay cavities in the lung of the operated hemithorax had occurred in 15 (88.2%) patients by the time of discharge from the hospital. Bacterial excretion finished in 15 (88.2%) operated in the hospital. In 2 (11.8%) of the operated, bacterial excretion decreased, but the decay cavity continued to be determined. The closure of the decay cavity in one of them was recorded in 3 months after the operation at the outpatient stage of treatment.
Conclusions. The proposed method of treatment allows achieving the closure of destructive cavities, resorption of infiltrative changes in the operated lung and abacillation of patients. The method is recommended for use in the treatment of various forms of multi-drug-resistant tuberculosis, which affects more than 5 segments of the lung when contraindications to resection methods of treatment are present.

Keywords: multi-drug-resistant pulmonary tuberculosis, bacterial excretion, surgical treatment, thoracoplasty, pneumoperitoneum
p. 138-145 of the original issue
  1. Global tuberculosis report 2016. Geneva: WHO; 2016. 201 p.
  2. Cegielski JP, Kurbatova E, van der Walt M, Brand J, Ershova J, Tupasi T, Caoili JC, Dalton T, Contreras C, Yagui M, Bayona J, Kvasnovsky C, Leimane V, Kuksa L, Chen MP, Via LE, Hwang SH, Wolfgang M, Volchenkov GV, Somova T, Smith SE, Akksilp S, Wattanaamornkiet W, Kim HJ, Kim CK, Kazennyy BY, Khorosheva T, Kliiman K, Viiklepp P, Jou R, Huang AS, Vasilyeva IA, Demikhova OV; Global PETTS Investigators, Lancaster J, Odendaal R, Diem L, Perez TC, Gler T, Tan K, Bonilla C, Jave O, Asencios L, Yale G, Suarez C, Walker AT, Norvaisha I, Skenders G, Sture I, Riekstina V, Cirule A, Sigman E, Cho SN, Cai Y, Eum S, Lee J, Park S, Jeon D, Shamputa IC, Metchock B, Kuznetsova T, Akksilp R, Sitti W, Inyapong J, Kiryanova EV, Degtyareva I, Nemtsova ES, Levina K, Danilovits M, Kummik T, Lei YC, Huang WL, Erokhin VV, Chernousova LN, Andreevskaya SN, Larionova EE, Smirnova TG. Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance. Clin Infect Dis. 2016 Feb 15;62(4):418-30. doi: 10.1093/cid/civ910
  3. Ojiezeh T, Ogundipe OO, Adefosoye VA. A retrospective study on incidence of pulmonary tuberculosis and human immunodeficiency virus co-infection among patients attending National Tuberculosis and Leprosy Control Programme, Owo centre. The Pan African Medical Journal. 2015;20:345. doi: 10.11604/pamj.2015.20.345.5643
  4. Todoriko LD, Volf SB, Kuzhko MM, Gelberg IS, Alekso EN, Semianiv IA. Contemporary aspects of tuberculosis problems analyzing the situation in some regions of Ukraine and Belarus. Zhurn GrGMU. 2016;(2):75-78. (in Russ.)
  5. Batyrrshina YaR, Krasnov VA, Petrenko TV. Treatment outcomes of multiple and extensive drug resistant tuberculosis and efficiency of surgical resections in patients with high risk. Tuberkulez i Bolezni Legkikh. 2016;94(5):28-34. doi: 10.21292/2075-1230-2016-94-5-28-34
  6. Prasad R, Singh A, Balasubramanian V, Gupta N. Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management. Indian J Med Res. 2017 Mar;145(3):271-93. doi: 10.4103/ijmr.IJMR_177_16
  7. Naidoo P, Theron G, Rangaka MX, Chihota VN, Vaughan L, Brey ZO, Pillay Y. The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges. J Infect Dis. 2017 Nov 6;216(Suppl_7):S702-S713. doi: 10.1093/infdis/jix335
  8. Laptev AN, Karatysh MI. Otdalennye rezul’taty rannego primeneniia ekstraplevral’noi torakoplastiki v kompleksnom lechenii bol’nykh infil’trativnym, tuberkulezom legkikh s mnozhestvennoi lekarstvennoi ustoichivost’iu. Med Panorama. 2010;(9):14-16. (in Russ.)
  9. Laniado-Laborín R. Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered. Expert Rev Respir Med. 2010 Apr;4(2):143-46. doi: 10.1586/ers.10.6
  10. The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB. WHO Regional Office for Europe; 2014. 17 .
  11. Yerimbetov KD, Zetov AS, Abildayev T, Bekembayeva GS, Ismailov SS. The effectiveness of surgical methods of treatment of pulmonary tuberculosis for patients with multidrug resistant at adequate chemotherapy (retrospective, case control, comparative research). Surg Sci. 2014;5(4):164-69. doi: 10.4236/ss.2014.54029
  12. Giller DB, Shaikhayev AYa, Tokayev KV, Yenilenis II, Martel II, Glotov AA, Papkov AV, Sadovnikova SS, Asanov BM, Giller GV, Volynkin AV, Barilo VN. Immediate results of surgical treatment in destructive pulmonary tuberculosis patients excreting extreme drug-resistant MBT. Tuberkulez i Bolezni Legkikh. 2010;(3):18-22. (in Russ.)
  13. Dheeraj S, Anula S, Sanjeev D, Rajendra MM. Thoracoplasty: a 15 year single centre experience. IOSR-JDMS. 2017;16(03):124-27 doi: 10.9790/0853-160306124127
  14. Krasnov D, Krasnov V, Skvortsov D, Felker I. Thoracoplasty for Tuberculosis in the Twenty-first Century. Thorac Surg Clin. 2017 May;27(2):99-11. doi: 10.1016/j.thorsurg.2017.01.003
  15. Omel’chuk DE, Tychkova IB. Effektivnost’ kollapsokhirurgicheskikh i kombinirovannykh vmeshatel’stv pri rasprostranennom fibrozno-kavernoznom tuberkuleze legkikh. Tuberkulez i Bolezni Legkikh. 2011;88(5):86. (in Russ.)
Address for correspondence:
40030, Ukraine,
Sumy, Troitskaya Str., 48,
Sumy State University,
Department of General Surgery,
Radiation Medicine and Phthisiology.
Tel. 8 (0542) 65-65-55,
Igor D. Duzhyi
Information about the authors:
Duzhyi Igor D., MD, Professor, Head of the Department of General Surgery, Radiation Medicine and Phthisiology, Medical Institute, Sumy State University, Sumy, Ukraine.
ravets Oleksandr V., PhD, Associate Professor of the Department of General Surgery, Radiation Medicine and Phthisiology, Medical Institute, Sumy State University, Sumy, Ukraine.
Popov Sergey V., MD, Professor of the Pediatrics Department, Medical Institute, Sumy State University, Sumy, Ukraine.
Hnatenko Ivan A., Post-Graduate Student of the Department of General Surgery, Radiation Medicine and Phthisiology, Medical Institute, Sumy State University, Sumy, Ukraine.



Samara State Medical University1,
Samara City Hospital 10 2, Samara,
The Russian Federation

Objective. To improve the treatment results of patients with uncomplicated femoral hernia by identifying the features of clinical course and reasonable application of the operation methods taking into account a possible destruction of the Cooper ligament.
Methods. The treatment analysis of 46 patients with uncomplicated femoral hernia was performed. There were 12 males (26%) and 34 females (74%). The control group included 24 patients with the repair of hernial orifice with local tissues. The main group included 22 patients in whom prosthetic repair has been used, including using the proposed method of operation. The results evaluation of the femoral canal repair in groups was performed according to the incidence of complications.
Results. In the control group, early complications occurred in 11 patients: hematoma in 3; inflammatory wound infiltration in 4; suppuration of the wound in 4. Late complications were found in 12 patients: pain in the surgical area in 4; parasthesia in 5; groin discomfort in 3, recurrence of the disease was revealed in 4. In the main group, early complications occurred in 4 patients: hematoma in 1, inflammatory wound infiltration in 1, wound suppuration in 1, seroma in 1. Late complications revealed in 3 patients: pain in the area of operation in 1, numbness in 1, discomfort in the inguinal region in 1, disease recurrence was found in 2. The use of prosthetic repair methods of the femoral canal reduced the incidence of early complications by 2.5 times, late complications by 3.7 times the number of the disease recurrence by 2 times.
Conclusions. Plastic surgery of the femoral canal with local tissues and with the use of prosthesis is limited when the ligament of Cooper is destroyed. The proposed method of operation with prosthesis with protrusion along the lower medial edge allows performing the operation when the tissue in the area of the femoral canal is destroyed.

Keywords: femoral hernia, prostheses and implants, diagnostics, operation methods, treatment results
p. 146-152 of the original issue
  1. Nyhus LM. Individualization of hernia repair: a new era. Surgery. 1993 Jul;114(1):1-2.
  2. Zhebrovskii VV, Il’chenko FN. Atlas operatsii pri gryzhakh zhivota. Simferopol’, Ukraina; 2004. 315 p. (in Russ.)
  3. Podluzhnyi VI, Krasnov OA, Kotov MS, Starchenkov SB. Pakhovaia i bedrennaia gryzhi: monogr. Kemerovo, RF; 2015. 143 p. (in Russ.)
  4. Whalen HR, Kidd GA, O’Dwyer PJ. Femoral hernias. BMJ. 2011 Dec 8;343:d7668. doi: 10.1136/bmj.d7668
  5. Babar M, Myers E, Matingal J, Hurley MJ. The modified Nyhus-Condon femoral hernia repair. Hernia. 2010 Jun;14(3):271-75. doi: 10.1007/s10029-009-0606-y
  6. Chen J, Lv Y, Shen Y, Liu S, Wang M. A prospective comparison of preperitoneal tension-free open herniorrhaphy with mesh plug herniorrhaphy for the treatment of femoral hernias. Surgery. 2010 Nov;148(5):976-81. doi: 10.1016/j.surg.2010.02.006
  7. Roth N, Gangl O, Havlicek W, Függer R. The impact of emergency surgery on results of femoral hernia repair. Eur Surg. 2010 Dec;42(6):299-303. doi: 10.1007/s10353-010-0573-7
  8. Humes DJ, Radcliffe RS, Camm C, West J. Population-based study of presentation and adverse outcomes after femoral hernia surgery. Br J Surg. 2013 Dec;100(13):1827-32. doi: 10.1002/bjs.9336
  9. Nilsson H, Stylianidis G, Haapamäki M, Nilsson E, Nordin P. Mortality after groin hernia surgery. Ann Surg. 2007 Apr;245(4):656-60. doi: 10.1097/01.sla.0000251364.32698.4b
  10. Dahlstrand U, Wollert S, Nordin P, Sandblom G, Gunnarsson U. Emergency femoral hernia repair: a study based on a national register. Ann Surg. 2009 Apr;249(4):672-76. doi: 10.1097/SLA.0b013e31819ed943
  11. Chan G, Chan CK. Longterm results of a prospective study of 225 femoral hernia repairs: indications for tissue and mesh repair. J Am Coll Surg. 2008 Sep;207(3):360-67. doi: 10.1016/j.jamcollsurg.2008.04.018
  12. Nasibyan AB. The problems of treatment of the patients with recurrent inguinal hernia and the ways of their solution. Aspirant Vestn Povolzh’ia. 2011;(5-6):147-50. (in Russ.)
  13. Dahlstrand U, Sandblom G, Wollert S, Gunnarsson U. Limited potential for prevention of emergency surgery for femoral hernia. World J Surg. 2014 Aug;38(8):1931-36. doi: 10.1007/s00268-014-2539-6
Address for correspondence:
443099, The Russian Federation,
Samara, Chapaevskaya Str., 89,
Samara State Medical University,
Department of Surgical Diseases 2.
Tel. office: +7 846 337-02-96,
e- mail:,
Vladimir I. Belokonev
Information about the authors:
Belokonev Vladimir I., Honored Doctor of the Russian Federation, MD, Professor, Head of the Department of Surgical Diseases 2, Samara State Medical University, Samara, Russian Federation.
Zharov Andrey V., Extramural Post-Graduate Student of the Department of Surgical Diseases 2, Samara State Medical University, Surgeon of Samara City Hospital 10 Samara, Russian Federation.



Rostov State Medical University, Rostov-on-Don,
The Russian Federation

Objective. To assess the wound repair in patients with pilonidal disease with open wound management and stimulation of healing by vacuum therapy.
Methods. The clinical study includes 73 patients who underwent open surgical treatment. There were 58 males (79.5%) and 15 females (20.5%). Patients were divided into the main group (n=39), where the original vacuum therapy after excision was carried out and the control group (n=34), where the excision of the pilonidal sinus was conducted with the open wound treatment by ointment bandage dressings. Clinical characteristics, cytological and planimetric parameters of healing were evaluated.
Results. In the main group, during the first week of treatment, a decrease in inflammation was observed, and by the second week granulation tissue formation resulted in purification and epithelization of the wound, and by the third week the optimum conditions for wound contraction and scar tissue formation were observed. At cytological examination, from the 8th day after the VAC-therapy, inflammatory response decreased in 32 (82.1%) patients, from the 12th days regenerative cytological patterns were determined in 12 (30.8%) patients. By the 16th day in 23 (59%) observations of the main group the wound regenerative processes were noted, and in the control group, inflammatory-regenerative cytograms prevailed 20 (58.8%). In the compared groups, it was found out that average healing and wound area reduction rate during the first 16 days of treatment was 2.6 times higher in main group.
Conclusions. Using VAC-therapy in postoperative wounds with open treatment of pilonidal disease promotes acceleration of healing and improves results of treatment in comparison with using standard bandage dressings.

Keywords: pilonidal sinus disease, surgical treatment, open wound healing, vacuum therapy, VAC-therapy, reparation
p. 153-160 of the original issue
  1. Titov AYu, Kostarev IV, Batischev AK. Etiopathogenesis and surgical treatment of epithelial pilonidal sinus. Ros Zhurn Gastroenterologii Gepatologii Koloproktologii. 2015;25(2):69-78.(data obrashcheniia: 2018 Sen 8). (in Russ.)
  2. Loganathan A, Arsalani Zadeh R, Hartley J. Pilonidal disease: time to reevaluate a common pain in the rear! Dis Colon Rectum. 2012 Apr;55(4):491-93. doi: 10.1097/DCR.0b013e31823fe06c
  3. Søndenaa K, Andersen E, Nesvik I, Søreide JA. Patient characteristics and symptoms in chronic pilonidal sinus disease. Int J Colorectal Dis. 1995;10(1):39-42. doi: 10.1007/BF00337585
  4. Iesalnieks I, Ommer A, Petersen S, Doll D, Herold A. German national guideline on the management of pilonidal disease. Langenbecks Arch Surg. 2016 Aug;401(5):599-609. doi: 10.1007/s00423-016-1463-7
  5. Gendy AS, Glick RD, Hong AR, Dolgin SE, Soffer SZ, Landers H, Herrforth M, Rosen NG. A comparison of the cleft lift procedure vs wide excision and packing for the treatment of pilonidal disease in adolescents. J Pediatr Surg. 2011 Jun;46(6):1256-59. doi: 10.1016/j.jpedsurg.2011.03.062
  6. McCallum I, King PM, Bruce J. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006213. doi: 10.1002/14651858.CD006213.pub2
  7. Segre D, Pozzo M, Perinotti R, Roche B. The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR). Tech Coloproctol. 2015 Oct;19(10):607-13. doi: 10.1007/s10151-015-1369-3
  8. Cherkasov MF, Galashokyan KM, Startsev YuM, Melikova SG, Cherkasov DM. Comparative study of treatment methods of pilonidal sinus. New Armenian Med J. 2016;10(4):67-71.
  9. Biter LU, Beck GM, Mannaerts GH, Stok MM, van der Ham AC, Grotenhuis BA. The use of negative-pressure wound therapy in pilonidal sinus disease: a randomized controlled trial comparing negative-pressure wound therapy versus standard open wound care after surgical excision. Dis Colon Rectum. 2014 Dec;57(12):1406-11. doi: 10.1097/DCR.0000000000000240
  10. Banasiewicz T, Bobkiewicz A, Borejsza-Wysocki M, Biczysko M, Ratajczak A, Malinger S, Drews M. Portable VAC therapy improve the results of the treatment of the pilonidal sinus--randomized prospective study. Pol Przegl Chir. 2013 Jul;85(7):371-76. doi: 10.2478/pjs-2013-0056
Address for correspondence:
344022, The Russian Federation,
Rostov-on-Don, Nakhichevansky Alley, 29,
Rostov State Medical University,
Department of Surgical Diseases.
Tel. +7 (918) 546 58 02,
Karapet M. Galashokyan
Information about the authors:
Cherkasov Mihail F., MD, Professor, Head of the Department of Surgical Diseases of the Faculty of Advanced Training and Retraining of Specialists, Rostov State Medical University, Rostov-on-Don, Russian Federation.
Galashokyan Karapet M., PhD, Assistant of the Department of Surgical Diseases of the Faculty of Advanced Training and Retraining of Specialists, Rostov State Medical University, Rostov-on-Don, Russian Federation.
Startsev Yury M., PhD, Associate Professor of the Department of Surgical Diseases of the Faculty of Advanced Training and Retraining of Specialists, Rostov State Medical University, Rostov-on-Don, Russian Federation.
Cherkasov Denis M., PhD, Associate Professor of the Department of Surgical Diseases 2, Rostov State Medical University, Rostov-on-Don, Russian Federation.
Pomazkov Andrey A., PhD, Associate Professor of the Department of Surgical Diseases of the Faculty of Advanced Training and Retraining of Specialists, Rostov State Medical University, Rostov-on-Don, Russian Federation.
Melikova Sabina G., Senior Laboratory Assistant of the Department of Surgical Diseases of the Faculty of Advanced Training and Retraining of Specialists, Rostov State Medical University, Rostov-on-Don, Russian Federation.



Volgograd State Medical University, Volgograd,
The Russian Federation

Objective. To establish the frequency and predictors of intestinal insufficiency syndrome in patients with bleeding from gastroduodenal ulcers, to clarify its role in the pathogenesis of systemic dysfunctions.
Methods. The study involved 149 patients with bleeding from gastroduodenal ulcers. The severity of endotoxicosis in the intestinal insufficiency syndrome and without was investigated, the relationship of the syndrome with the formation of other systemic dysfunctions (for example, hepatic and renal failure) was traced.
Results. In the dynamics from the 1st to the 5th day of hospital stay, intestinal insufficiency syndrome was found in 72 (65%) patients out of 110 (110/149 74%) patients with only severe degrees of blood loss. In 90% of cases, the development of intestinal insufficiency syndrome was preceded by hypotension (systolic pressure <70 mmHg) of over 80 minutes duration. Ischemic-reperfusion injury of the small intestine wall led to the violation of its barrier function and a flood of blood with intraintestinal toxins, increasing systemic endotoxicosis reliably more significantly than in patients without the syndrome of intestinal insufficiency. In patients with the syndrome of intestinal insufficiency, systemic dysfunctions developed in 90% (65/72) of cases, and without it, only in 11% (4/38) of cases (p<0.05). This is explained by the fact that in the syndrome of intestinal insufficiency, an additional long-term toxic effect on the liver and kidneys leads to a breakdown in the adaptive capacities of their main functions, the violation of which extremely negatively affects homeostasis indicators. Mortality in the group with the intestinal insufficiency syndrome was 15% (11/72), and mortality in the group without the intestinal insufficiency syndrome was 5% (2/38).
Conclusions. 65% of patients with severe bleeding from gastroduodenal ulcers develop the intestinal insufficiency syndrome, which plays a significant negative role in the potentiation of systemic endotoxicosis, as a consequence in the formation of systemic dysfunctions and the outcome of the disease as a whole.

Keywords: syndrome of intestinal insufficiency, severe bleeding, ischemic-reperfusion injury, small intestine wall, barrier function, endotoxicosis
p. 161-167 of the original issue
  1. Stepanov IuM, Zalevskii VI, Kosinskii AV. Zheludochno-kishechnye krovotecheniia: Dnepropetrovsk: Lira; 2011. 270 p. (in Russ.)
  2. Feinman M, Haut ER. Upper gastrointestinal bleeding. Surg Clin North Am. 2014 Feb;94(1):43-53. doi: 10.1016/j.suc.2013.10.004
  3. Gel’fand BR, Saltanov AI. Intensivnaia terapiia: nats ruk. Moscow, RF: GEOTAR-Media; 2009. V.I. 960 p. (in Russ.)
  4. Sarsu SB, Ozokutan BH, Tarakcioglu M, Sarı I, Bağcı C. Effects of leptin on intestina lischemia-reperfusion injury. Indian J Surg. 2015 Dec;77(Suppl 2):351-55. doi: 10.1007/s12262-013-0836-1
  5. Cosse C, Sabbagh C, Kamel S, Galmiche A, Regimbeau JM. Procalcitonin and intestinal ischemia: a review of the literature. World J Gastroenterol. 2014 Dec 21;20(47):17773-78. doi: 10.3748/wjg.v20.i47.17773
  6. Klimovich IN, Maskin SS, Snigur GL, Abramov PV, Pavlov AV. Intestinal insufficiency in pathogenesis of endotoxicosis in hemorrhagic hypotension. Novosti Khirurgii. 2018 May-Jun; 26(3):276-283. doi: 10.18484/2305-0047.2018.3.276 (in Russ.)
  7. Peng Z, Ban K, Wawrose RA, Gover AG, Kozar RA. Protection by enteral glutamine is mediated by intestinal epithelial cell peroxisome proliferator-activated receptor-γ during intestinal ischemia/reperfusion. Shock. 2015 Apr;43(4):327-33. doi: 10.1097/SHK.0000000000000297
  8. Gordeeva AE, Temnov AA, Charnagalov AA, Sharapov MG, Fesenko EE, Novoselov VI. Protective effect of peroxiredoxin 6 in ischemia/reperfusion-induced damage of small intestine. Dig Dis Sci. 2015 Dec;60(12):3610-19. doi: 10.1007/s10620-015-3809-3
  9. Gostishchev VK, Evseev MA. Gastroduodenal’nye krovotecheniia iazvennoi etiologii (patogenez, diagnostika, lechenie): ruk. Moscow, RF: GEOTAR-Media; 2008. 384 p. (in Russ.)
  10. Kamyshnikov VS, red. Metody klinicheskikh laboratornykh issledovanii. Moscow, RF: MEDpress-inform, 2009. 751 p. (in Russ.)
  11. Kudaeva IV, Masnavieva LB. The methods for assessing oxidative status in laboratory practice. Med Alfavit. 2015;1(2):14-18. (in Russ.)
  12. Kostyuk VA, Potapovich AI, Kovaleva ZnV. A simple sensitive assay for determination of superoxide dismutase activity based on reac­tion of quercetin oxidation. Vopr Med Khimii. 1990;36(2):88-91. (in Russ.)
  13. Petri A, Sebin K. Nagliadnaia meditsinskaia statistika. Leonov VP, red. Moscow, RF: GEOTAR-Media; 2009. 168 p. (in Russ.)
Address for correspondence:
400131, The Russian Federation,
Volgograd, Pavshih Boyzov Square, 1,
Volgograd State Medical University,
Department of Hospital Surgery.
Tel. office: 8(442) 71-87-62,
Tel. mobile: +7 905-336-23-69,
Igor N. Klimovich
Information about the authors:
Klimovich Igor N., MD, Professor of the Department of Hospital Surgery, Volgograd State Medical University, Volgograd, Russian Federation.
Maskin Sergey S., MD, Professor, Head of the Department of Hospital Surgery, Volgograd State Medical University, Volgograd, Russian Federation.
Abramov Pavel V., Post-Graduate Student, the Department of Hospital Surgery, Volgograd State Medical University, Volgograd, Russian Federation.
Pavlov Alexandr V., PhD, Assistant of the Department of Hospital Surgery, Volgograd State Medical University, Volgograd, Russian Federation.




Kharkiv National Medical University, Kharkiv,

Objective. Determining the anatomical variability of the upper maxillary sinus and ostiomeatal complex components as well as on the basis of the obtained data the selection of the optimal access to the zones of the maxillary sinus to choose sinusitis treatment method, which allows minimizing intra- and postoperative complications.
Methods. The results of studies of the paranasal sinuses of 30 patients conducted on the spiral computed tomography were studied: 10 with the subtotal reduction of pneumatization of the maxillary sinus and 10 patients with hyperplasia of the mucous membrane. The control group included 10 SCTs of healthy individuals. The average volume, bone density of the maxillary sinus, the average size of the inferior nasal turbinate, the size, density of processus uncinatus under physiological and pathological conditions, the correlation between these parameters were determined.
Results. A significant correlation (r=0.96, 0.96, 0.95, and 0.9 in the physiological state and r=0.95, 0.94, 0.97, and 0.91 in sinusitis) was noted between the volume, thickness and the density of the walls of the maxillary sinus. A moderate correlation was between the volume of the sinus, the thickness and density of the processus uncinatus, the volume of the sinus and the longitudinal size of the inferior turbinate in the unchanged sinus (r=0.65, 0.68 and 0.66). A very strong correlation was between the thickness of the upper wall and the volume of the sinus (r=0.96). A strong positive linear relationship (r=0.72) is noted between the volume and thickness of the medial wall (p<0.05). The reliable (p<0.01) strong (r=0.75) interconnection was between the thickness of the processus uncinatus and the average sinus volume. Very strong linear correlation was between the density of the middle and upper walls of the maxillary sinus in physiological and pathological conditions (r=0.9 and 0.84)
Conclusions. Spiral computed tomography is a diagnostically significant method for the study of the maxillary sinuses. Parameters of the paranasal sinuses necessary for successful endoscopic rhinosurgery were determined. The obtained data helps to choose access during endoscopic operations, to prevent intra-, postoperative complications, to predict the likelihood of intracranial or intraocular spread of the pathological process.

Keywords: paranasal sinuses, maxillary sinus, density, processus uncinatus, inferior turbinate
p. 168-176 of the original issue
  1. Shcherbakov DA, Kryukov AI, Krasnozhen VN, Hukumatshoev AI, Karimova AI. Certain morphometric characteristics of the normal maxillary sinus. [Article in Russian]; Abstract available in Russian from the publisher Vestn Otorinolaringol. 2017;82(4):44-47. doi: 10.17116/otorino201782444-47
  2. Denga O, Pyndus T, Gargin V, Schneider S. Influence of metabolic syndrome on condition of microcirculatory bed of oral cavity. Georgian Med News. 2017 Dec;(273):99-104.
  3. Tahmasbi-Arashlow M, Barghan S, Bennett J, Katkar RA, Nair MK. Arrested pneumatization of the sphenoid sinus on large field-of-view cone beam computed tomography studies. Dent J (Basel). 2015 May 11;3(2):67-76. doi: 10.3390/dj3020067
  4. Fokkens WJ, Bachert C, Bernal-Sprekelsen M, Bousquet J, Djandji M, Dorenbaum A, Hakimi-Mehr D, Hendry S, Hopkins C, Leunig A, Mannent L, Mucha D, Onerci M, Pugin B, Toppila-Salmi S, Rowe P, Seys SF, Stimson S, Strzembosz A, Hellings PW. Rhinology Future Debates, an EUFOREA Report. Rhinology. 2017 Dec 1;55(4):298-304. doi: 10.4193/Rhin17.221
  5. Kovach I, Buniatian K, Makarevych A, Verbyts’ka A, Gargin V. Influence of tricalcium silicate on course of traumatic pulpitis. Georgian Med News. 2018 Mar;(276):130-34.
  6. Drumond JP, Allegro BB, Novo NF, de Miranda SL, Sendyk WR. Evaluation of the prevalence of maxillary sinuses abnormalities through spiral computed tomography (CT). Int Arch Otorhinolaryngol. 2017 Apr;21(2):126-33. doi: 10.1055/s-0036-1593834
  7. Farneti P, Sciarretta V, Macrì G, Piccin O, Pasquini E. Silent sinus syndrome and maxillary sinus atelectasis in children. Int J Pediatr Otorhinolaryngol. 2017 Jul;98:150-57. doi: 10.1016/j.ijporl.2017.05.005
  8. Bhushan B, Rychlik K, Schroeder JW Jr. Development of the maxillary sinus in infants and children. Int J Pediatr Otorhinolaryngol. 2016 Dec;91:146-51. doi: 10.1016/j.ijporl.2016.10.022
  9. Piskunov SZ, Piskunov IS, Piskunov VS. The anatomic features and functional and clinical value of the hamulus. Ros Rinologiia. 2014;22(3):26-32. (in Russ.)
  10. Mendiratta V, Baisakhiya N, Singh D, Datta G, Mittal A, Mendiratta P. Sinonasal anatomical variants: CT and endoscopy study and its correlation with extent of disease. Indian J Otolaryngol Head Neck Surg. 2016 Sep;68(3):352-58. doi: 10.1007/s12070-015-0920-x
  11. Socher JA, Mello J, Baltha BB. Tomographical findings in adult patients undergoing endoscopic sinus surgery revision. Int Arch Otorhinolaryngol. 2018 Jan;22(1):73-80. doi: 10.1055/s-0037-1601417
  12. Liu J, Dai J, Wen X, Wang Y, Zhang Y, Wang N. Imaging and anatomical features of ethmomaxillary sinus and its differentiation from surrounding air cells. Surg Radiol Anat. 2018 Feb;40(2):207-15. doi: 10.1007/s00276-018-1974-8
  13. Magill D, Beckmann N, Felice MA, Yoo T, Luo M, Mupparapu M. Investigation of dental cone-beam CT pixel data and a modified method for conversion to Hounsfield unit (HU). Dentomaxillofac Radiol. 2018 Feb;47(2):20170321. doi: 10.1259/dmfr.20170321
  14. Baimenov AZ. The early prophylaxis of postoperative stenosis by means of modified endonasal functional dacryocystorhinostomy. Vestn Otorinolaringol. 2015;80(2):60-62. doi: 10.17116/otorino201580260-62
  15. Kaya M, Çankal F, Gumusok M, Apaydin N, Tekdemir I. Role of anatomic variations of paranasal sinuses on the prevalence of sinusitis: Computed tomography findings of 350 patients. Niger J Clin Pract. 2017 Nov;20(11):1481-88. doi: 10.4103/njcp.njcp_199_16
Address for correspondence:
61022, Ukraine,
Kharkiv, Nauki Ave., 4,
Kharkiv National Medical University,
Department of Histology,
Cytology and Embryology.
Tel. +380982589078,
Victoriia V. Alekseeva
Information about the authors:
Lupyr Andrii V., MD, Associate Professor of Otolaryngology Department, Kharkiv National Medical University, Kharkiv, Ukraine.
Alekseeva Victoriia V., Assistant of the Department of Histology, Cytology and Embryology, Kharkiv National Medical University, Kharkiv, Ukraine.
Urevich Nadejda A., PhD, Associate Professor of Otolaryngology Department, Kharkiv National Medical University, Kharkiv, Ukraine.
Nazaryan, Rosana S., MD, Professor, Head of the Department of Pediatric Dentistry, Pediatric Maxillofacial Surgery and Implantology, Kharkiv National Medical University, Kharkiv, Ukraine.
Gargin Vitaliy V, MD, Professor of the Pathologic Anatomy Department, Kharkiv National Medical University, Kharkiv, Ukraine.




N.N. Alexandrov National Cancer Centre of Belarus, Minsk,
The Republic of Belarus

Objective. To evaluate the results of the repeated colon interposition for esophageal replacement in the esophageal and gastroesophageal junction carcinomas surgical treatment.
Methods. Repeated colon interposition after discontinuity resections for ischemic complications of primary gastric or jejunal pull up procedures during the esophageal and gastroesophageal junction carcinomas surgical treatment was implemented in 40 patients. Squamous cell esophageal carcinoma was represented in 52.5% (21/40) observations and gastroesophageal junction adenocarcinoma in 47.5% (19/40). Patients mean age was 56.0 (52.0, 63.0) years, body mass index 21.4 (18.9, 24.5) units. Male patients predominated over females 90% (36/40) and 10% (4/40) respectively. Repeated reconstructions were preceded by previously performed discontinuity procedures. Esophago-gastric anastomosis resection was performed in 57.5% (23/40) patients, gastric conduit removal ― in 7.5% (3/40), esophageal demucosation with complicated anastomosis resection ― in 35% (14/40).
Results. Time of procedures was 345.0 (310.0, 407.5) minutes, blood loss 400.0 (300.0, 500.0) ml, in-hospital stay 27.5 (21.0, 40.5) days. Esophago-colonic anastomosis leakage and/or an oral end graft necrosis were detected clinically and radiologically on the 8th day after surgery. Anastomotic leakage developed in 12.5% (5/40) observations, graft loss in 5% (2/40). Late esophageal anastomotic strictures, determined by means of esophagocolonoscopy 3 months after the repeated esophagoplasty, were formed in 7.5% (3/40) patients. 30- and 60-day mortality rate made up 7.5% (3/40) and 10% (4/40) cases respectively. Overall 5-year survival was 26.9%.
Conclusions. Repeated colon interposition for esophageal replacement in esophageal and gastroesophageal junction carcinomas surgical treatment is a salvage procedure for patients who undergo discontinuity surgical interventions which allows achieving satisfactory long-term treatment outcomes.

Keywords: esophageal carcinoma, gastroesophageal junction carcinoma, repeated esophageal replacement by colon interposition, retrosternal route of graft translocation, discontinuity procedure, esophageal demucosation
p. 177-187 of the original issue
  1. Vijay K, Godara R, Vijayvergia V. Failed Gastric Pull up after Esophagectomy Managed by Colonic Interposition. Indian J Surg. 2013 Jun;75(Suppl 1):347-49. doi: 10.1007/s12262-012-0662-x
  2. Kesler KA, Pillai ST, Birdas TJ, Rieger KM, Okereke IC, Ceppa D, Socas J, Starnes SL. “Supercharged” isoperistaltic colon interposition for long-segment esophageal reconstruction. Ann Thorac Surg. 2013 Apr;95(4):1162-68; discussion 1168-9. doi: 10.1016/j.athoracsur.2013.01.006
  3. Reslinger V, Tranchart H, D’Annunzio E, Poghosyan T, Quero L, Munoz-Bongrand N, Corte H, Sarfati E, Cattan P, Chirica M. Esophageal reconstruction by colon interposition after esophagectomy for cancer analysis of current indications, operative outcomes, and long - term survival. J Surg Oncol. 2016 Feb;113(2):159-64. doi: 10.1002/jso.24118
  4. Sacak B, Orfaniotis G, Nicoli F, Liu EW, Ciudad P, Chen SH, Chen HC. Back-up procedures following complicated gastric pull-up procedure for esophageal reconstruction: Salvage with intestinal flaps. Microsurgery. 2016 Oct;36(7):567-72. doi: 10.1002/micr.22520
  5. Fisher RA, Griffiths EA, Evison F, Mason RC, Zylstra J, Davies AR, Alderson D, Gossage JA. A national audit of colonic interposition for esophageal replacement. Dis Esophagus. 2017 May 1;30(5):1-10. doi: 10.1093/dote/dow003
  6. Awsakulsutthi S, Havanond C. A retrospective study of anastomotic leakage between patients with and without vascular enhancement of esophageal reconstructions with colon interposition: Thammasat University Hospital experience. Asian J Surg. 2015 Jul;38(3):145-49. doi: 10.1016/j.asjsur.2015.01.005
  7. Uchiyama H, Shirabe K, Morita M, Kakeji Y, Taketomi A, Soejima Y, Yoshizumi T, Ikegami T, Harada N, Kayashima H, Morita K, Maehara Y. Expanding the applications of microvascular surgical techniques to digestive surgeries: a technical review. Surg Today. 2012 Jan;42(2):111-20. doi: 10.1007/s00595-011-0032-5
  8. Ilyin IA, Malkevich VT. Repeated and delayed esophagoplasty in esophageal and gastroesophageal cancer treatment. Izv NAN Belarusi. Ser Med Nauk. 2016;(2):15-22. (in Russ.)
  9. Saeki H, Morita M, Harada N, Egashira A, Oki E, Uchiyama H, Ohga T, Kakeji Y, Sakaguchi Y, Maehara Y. Esophageal replacement by colon interposition with microvascular surgery for patients with thoracic esophageal cancer: the utility of superdrainage. Dis Esophagus. 2013 Jan;26(1):50-56. doi: 10.1111/j.1442-2050.2012.01327.x
  10. Kassis ES, Kosinski AS, Ross P Jr, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013 Dec;96(6):1919-26. doi: 10.1016/j.athoracsur.2013.07.119
  11. Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012 Jul;256(1):95-103. doi: 10.1097/SLA.0b013e3182590603
  12. Klink CD, Binnebösel M, Schneider M, Ophoff K, Schumpelick V, Jansen M. Operative outcome of colon interposition in the treatment of esophageal cancer: a 20-year experience. Surgery. 2010 Apr;147(4):491-96. doi: 10.1016/j.surg.2009.10.045
  13. Brown J, Lewis WG, Foliaki A, Clark GWB, Blackshaw GRJC, Chan DSY. Colonic Interposition After Adult Oesophagectomy: Systematic Review and Meta-analysis of Conduit Choice and Outcome. J Gastrointest Surg. 2018 Jun;22(6):1104-11. doi: 10.1007/s11605-018-3735-8
  14. Bakshi A, Sugarbaker DJ, Burt BM. Alternative conduits for esophageal replacement. Ann Cardiothorac Surg. 2017 Mar;6(2):137-43. doi: 10.21037/acs.2017.03.07
  15. Ceroni M, Norero E, Henríquez JP, Viñuela E, Briceño E, Martínez C, Aguayo G, Araos F, GonzÁlez P, Díaz A, Caracci M. Total esophagogastrectomy plus extended lymphadenectomy with transverse colon interposition: a treatment for extensive esophagogastric junction cancer. World J Hepatol. 2015 Oct 8;7(22):2411-17. doi: 10.4254/wjh.v7.i22.2411
  16. Malkevich VT, Zharkov VV, Ositrova LI, Kurchin VP, Baranov AYu, Ilyin I.A. New approaches to treatment of intrapleural complications in esophageal cancer surgery. Novosti Khirurgii. 2012;20(3):74-80. (in Russ.)
  17. Okeanov AE, Moiseev PI, Levin LF, Evmenenko AA, Sukonko OG. (red). Statistika onkologicheskikh zabolevanii v Respublike Belarus’ (2007-2016)=Statistics of cancer diseases in the Republic of Belarus (2007-2016): analiticheskii obzor po dannym Belorusskogo kantser-registra. Minsk, RB: RNPTs OMR; 2017. 286 p. (in Russ.)
Address for correspondence:
223040, The Republic of Belarus,
Minsk region, Lesnoy 2,
N.N. Alexandrov National Cancer
Centre of Belarus,
Surgical Department.
Tel. office.: 8 017 389 95 32,
Ilya A. Ilyin
Information about the authors:
Ilyin Ilya A., PhD, Leading Researcher of the Surgical Department, N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Republic of Belarus.




Vitebsk State Medical University 1, Vitebsk,
Minsk Scientific and Practical Center of Surgery, Transplantation and Hematology 2, Minsk,
The Republic of Belarus

Objective. To establish factors of phenotypic and genotypic resistance of the most problematic infectious agents in the intensive care unit.
Methods. A comprehensive examination of 224 clinical isolates from the sputum of 99 patients in the intensive care unit was performed. Carbapenemase genes in Klebsiella pneumonia isolates were detected by real-time polymerase chain reaction and minimum inhibitory concentrations of antibiotics for microorganisms were determined in planktonic form and biofilm form by the method of double serial dilutions.
Results. In the structure of the studied isolates the most common were Acinetobacter spp. (32.6%), Klebsiella pneumonia (33.5%), Pseudomonas aeruginosa (14.7%). 91.4% of Klebsiella pneumoniae isolates possessed genes of resistance and in most cases OXA-48 (80%). All the studied isolates moderately or well formed the biofilm, among the studied microorganisms Proteus mirabilis demonstrated this ability best of all. All isolates both in plankton form and in the form of biofilm were sensitive to tigecycline (100%) and resistant to carbapenems in 94.7%, to cephalosporins in 100% of cases. For 90% of the studied isolates the minimum inhibitory concentration for tigecycline and ciprofloxacin in the biofilm does not change and increases for moxifloxacin in 1.3 times, for meropenem 1.2 times.
Conclusions. The factors of phenotypic and genotypic resistance of the most problematic infectious agents in the intensive care unit have been established. Most of the carbapenemresistant Klebsiella pneumoniae isolates (88.5%) had gene associations: OXA-48 and CTX-M (37.1%), NDM and CTX-M (2.9%), NDM and OXA-48 (37.1%), CTX-M and OXA-48 (11.4%). The identification of resistance genes that determine the synthesis of carbapenemazes and cefalosporinazes eliminates the antibiotics that are destroyed by these enzymes from the algorithms of antibacterial therapy.

Keywords: antibiotic resistance, Klebsiella pneumoniae, Acinetobacter spp., Pseudomonas aeruginosa, biofilm formation, resistance genes
p. 188-195 of the original issue
  1. Mukhopadhyay C. Infection Control in Intensive Care Units. Indian J Respir Care. 2018;(7):14-21. doi: 10.4103/ijrc.ijrc_9_17
  2. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000 Jul;118(1):146-55. doi: 10.1378/chest.118.1.146
  3. Yakovlev SV, Suvorova MP, Beloborodov VB, Basin EE, Eliseev EV, Kovelenov SV, Porthyagina US, Rog AA, Rudnov VA, Barkanova ON. Multicentre study of the prevalence and clinical value of hospital-acquired infections in emergency hospitals of Russia: ergini study. Antibiotiki i Khimioterapiia. 2016;61(5-6):32-42. (in Russ.)
  4. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009 Nov;136(5):1237-48. doi: 10.1378/chest.09-0087
  5. Zubkov MN. Rol’ karbapenemov v usloviiakh eskalatsii antibiotikorezistentnosti gramotritsatel’nykh bakterii. RMZh. 2008;16(2): 106-12. (in Russ.)
  6. Zemko VYu, Okulich VK, Dzvadz‘kcr AM. Monitoring the antibiotic resistance in the intensive care unit of a multidisciplinary hospital. Transplantologiia. 2018;10(4):284-97. doi: 10.23873/2074-0506-2018-10-4-284-297 (in Russ.)
  7. Lazareva IV. Ageevets VA, Ershova TA, Zueva LP, Goncharov AE, Darina MG, Svetlichnaya YuS, Uskov AN, Sidorenko SV. Prevalence and antibiotic resistance of carbapenemase-producing gram-negative bacteria in Saint-Petersburg and some other regions of the Russian Federation. Antibiotiki i Khimioterapiia. 2016;61:11-12. (in Russ.)
  8. Vorobey ES, Voronkova S, Vinnikov AI. Bacterial biof1lms. “Bacteria quorum” sensing in biofilms. Visnik Dnipropetrovs’kogo universitetu. Biologiia. Ekologiia. 2012;20 (1):13-22. (in Ukr.)
  9. Glushanova NA, Blinov AI, Alekseeva NB. Bacterial biofilms in human infectious pathology. Meditsina v Kuzbasse. 2015:30-35. (in Russ.)
  10. Lopukhov LV, Edelstein MV. Polymerase chain reaction in diagnostic clinical microbiology. Klin Mikrobiologiia i Antimikrobnaia Khimioterapiia. 2000;4(2):96-106. (in Russ.)
  11. Kolomiets ND, Tonko OV, Serookaia TI, Mareiko AM, Litunovskaia LG, Ermakova GS, Kolodkina VL, Sergeichik NL, Levshina NN, Slavinskaia AA, Tochko NI, Voitik SB, Novomliianova LV, Shitikova PV, Kliuiko NL, Kulichkovskaia IV. Mikrobiologicheskie metody issledovaniia biologicheskogo materiala: instruktsiia po primeneniiu; 075-0210. Minsk, RB: Dikta; 2010; 75 p. (in Russ.)
  12. Okulich VK, Kabanova AA, Plotnikov FV. Mikrobnye bioplenki v klinicheskoi mikrobiologii i antibakterial’noi terapii: monogr. Vitebsk, RB; 2017. 300 p. (in Russ.)
  13. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1, 2018.
  14. Hamprecht A, Gottig S. Treatment of infections caused by carbapenem-resistant Enterobacteriaceae. Curr Treat Options Infect Dis. 2014;6(4):425-38. doi: 10.1007/s40506-014-0029-x
  15. Saini R, Saini S, Sharma S. Biofilm: A dental microbial infection. J Nat Sci Biol Med. 2011 Jan-Jun;2(1):71-75. doi: 10.4103/0976-9668.82317
Address for correspondence:
210009, The Republic of Belarus,
Vitebsk, Frunze Avenue, 27,
Vitebsk State Medical University,
Department of Anesthesiology and Resuscitation
With a Course of the Faculty of the Advanced
Training and Retraining of Specialists.
Tel. mobile +375291460799,
Viktoryia Yu. Ziamko
Information about the authors:
Ziamko Viktoryia Yu., Post-Graduate Student of the Department of Anesthesiology and Resuscitation with a Course of the Faculty of the Advanced Training and Retraining of Specialists, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
Okulich Vitaly K., PhD, Associate Professor of the Clinical Microbiology Department, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
Dzyadzko Alexander M., MD, Head of the Intensive Care Unit, Minsk Scientific and Practical Center of Surgery, Transplantation and Hematology, Minsk, Republic of Belarus.




Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Branch 1,
Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine 2,
The Russian Federation

Mesenchymal stem/stromal cells (MSC) have been widely used for tissue regeneration including the repair of bone defects. However, shortcomings of MSC application, including the limited term of existence in tissues, have become an obstacle for further direct transplantation of MSC.
There is a necessary to create new methods of cell therapy that do not have the disadvantages of the direct MSC application, but which influence the bone tissue regeneration with the same effectiveness.
Cells influence each other and exchange the functional proteins and genetic material through the secretion of exosomes which can be also applied for the impact on tissue regeneration. Exosomes strengthen proliferation, migration and act as the inductors of differentiation of MSC in the determined direction including osteogenic one that leads to the considerable acceleration of bone defect reparation. The delivery of microRNA and various regulating cytokines is a possible mechanism of optimization of tissue reparation by exosomes. The action of exosomes to a large extent is similar to effects of MSC. The creation of animals with preset properties has good prospects. However, the assessment of therapeutic potential and use in future clinical tests of the extracellular vesicles secreted by various cells, demands their total characteristic, standardization of strictly particular conditions of storage and receiving, removal xenogenic and others substances, bound to the source.
The application of exosomes has high potential for reparative medicine, in particular, for acceleration of bone tissue regeneration, and opens new paths of medical research.

Keywords: regeneration of bone tissue, mesenchymal stromal cells, exosomes, microvesicles, cell interaction
p. 196-203 of the original issue
  1. Maiborodin IV, Matveyeva VA, Kolesnikov IS, Drovosekov MN, Toder MS, Shevela AI. Regeneration of the damaged mandibular bone in rat after the injection of autologous mesenchymal stem cells of bone marrow origin adsorbed on the fibrin clot. Morfologiia. 2011;140(6):79-85. (in Russ.)
  2. Lu Z, Chen Y, Dunstan C, Roohani-Esfahani S, Zreiqat H. Priming adipose stem cells with tumor necrosis factor-alpha preconditioning potentiates their exosome efficacy for bone regeneration. Tissue Eng Part A. 2017 Nov;23(21-22):1212-20. doi: 10.1089/ten.tea.2016.0548
  3. Takeda YS, Xu Q. Neuronal differentiation of human mesenchymal stem cells using exosomes derived from differentiating neuronal cells. PLoS One. 2015 Aug 6;10(8):e0135111. doi: 10.1371/journal.pone.0135111
  4. Pachler K, Lener T, Streif D, Dunai ZA, Desgeorges A, Feichtner M, Öller M, Schallmoser K, Rohde E, Gimona M. A Good manufacturing practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles. Cytotherapy. 2017 Apr;19(4):458-72. doi: 10.1016/j.jcyt.2017.01.001
  5. Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, O’Driscoll L, Fais S, Falcon-Perez JM, Felderhoff-Mueser U, Fraile L, Gho YS, Görgens A, Gupta RC, Hendrix A, Hermann DM, Hill AF, Hochberg F, Horn PA, de Kleijn D, Kordelas L, Kramer BW, Krämer-Albers EM, Laner-Plamberger S, Laitinen S, Leonardi T, Lorenowicz MJ, Lim SK, Lötvall J, Maguire CA, Marcilla A, Nazarenko I, Ochiya T, Patel T, Pedersen S, Pocsfalvi G, Pluchino S, Quesenberry P, Reischl IG, Rivera FJ, Sanzenbacher R, Schallmoser K, Slaper-Cortenbach I, Strunk D, Tonn T, Vader P, van Balkom BW, Wauben M, Andaloussi SE, Théry C, Rohde E, Giebel B. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015 Dec 31;4:30087. doi: 10.3402/jev.v4.30087
  6. Doeppner TR, Herz, Görgens A, Schlechter J, Ludwig AK, Radtke S, de Miroschedji K, Horn PA, Giebel B, Hermann DM. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015 Oct;4(10):1131-43. doi: 10.5966/sctm.2015-0078
  7. Huang CC, Narayanan R, Alapati S, Ravindran S. Exosomes as biomimetic tools for stem cell differentiation: applications in dental pulp tissue regeneration. Biomaterials. 2016 Dec;111:103-15. doi: 10.1016/j.biomaterials.2016.09.029
  8. Narayanan R, Huang CC, Ravindran S. Hijacking the cellular mail: exosome mediated differentiation of mesenchymal stem cells. Stem Cells Int. 2016;2016:3808674. doi: 10.1155/2016/3808674
  9. Furuta T, Miyaki S, Ishitobi H, Ogura T, Kato Y, Kamei N, Miyado K, Higashi Y, Ochi M. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl Med. 2016 Dec;5(12):1620-30. doi: 10.5966sctm.2015-0285
  10. Qin Y, Sun R, Wu C, Wang L, Zhang C. Exosome: a novel approach to stimulate bone regeneration through regulation of osteogenesis and angiogenesis. Int J Mol Sci. 2016 May 19;17(5). pii: E712. doi: 10.3390/ijms17050712
  11. Silva AM, Almeida MI, Teixeira JH, Maia AF, Calin GA, Barbosa MA, Santos SG. Dendritic cell-derived extracellular vesicles mediate mesenchymal stem/stromal cell recruitment. Sci Rep. 2017 May 10;7(1):1667. doi: 10.1038/s41598-017-01809-x
  12. Zhang J, Liu X, Li H, Chen C, Hu B, Niu X, Li Q, Zhao B, Xie Z, Wang Y. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther. 2016 Sep 20;7(1):136. doi: 10.1186/s13287-016-0391-3
  13. Zhang S, Chu WC, Lai RC, Lim SK, Hui JH, Toh WS. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage. 2016 Dec;24(12):2135-40. doi: 10.1016/j.joca.2016.06.022
  14. Wang KX, Xu LL, Rui YF, Huang S, Lin SE, Xiong JH, Li YH, Lee WY, Li G. The effects of secretion factors from umbilical cord derived mesenchymal stem cells on osteogenic differentiation of mesenchymal stem cells. PLoS One. 2015 Mar 23;10(3):e0120593. doi: 10.1371/journal.pone.0120593. eCollection 2015.
  15. Qi X, Zhang J, Yuan H, Xu Z, Li Q, Niu X, Hu B, Wang Y, Li X. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int J Biol Sci. 2016 May 25;12(7):836-49. doi: 10.7150/ijbs.14809. eCollection 2016.
  16. Torreggiani E, Perut F, Roncuzzi L, Zini N, Baglìo SR, Baldini N. Exosomes: novel effectors of human platelet lysate activity. Eur Cell Mater. 2014 Sep 22;28:137-51; discussion 151. doi: 10.22203/eCM.v028a11
  17. Ekström K, Omar O, Granéli C, Wang X, Vazirisani F, Thomsen P. Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells. PLoS One. 2013 Sep 18;8(9):e75227. doi: 10.1371/journal.pone.0075227. eCollection 2013.
  18. Namazi H, Mohit E, Namazi I, Rajabi S, Samadian A, Hajizadeh-Saffar E, Aghdami N, Baharvand H. Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA. J Cell Biochem. 2018 May;119(5):4150-60. doi: 10.1002/jcb.26621
  19. Selvasandran K, Makhoul G, Jaiswal PK, Jurakhan R, Li L, Ridwan K, Cecere R. A tumor necrosis factor-α and hypoxia-induced secretome therapy for myocardial repair. Ann Thorac Surg. 2018 Mar;105(3):715-23. doi: 10.1016/j.athoracsur.2017.09.005
  20. Gonzalez-King H, García NA, Ontoria-Oviedo I, Ciria M, Montero JA, Sepúlveda P. Hypoxia inducible factor-1α potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes. Stem Cells. 2017 Jul;35(7):1747-59. doi: 10.1002/stem.2618
  21. Hnatiuk AP, Ong SG, Olea FD, Locatelli P, Riegler J, Lee WH, Jen CH, De Lorenzi A, Giménez CS, Laguens R, Wu JC, Crottogini A. Allogeneic mesenchymal stromal cells overexpressing mutant human hypoxia-inducible factor 1-α (hif1-α) in an ovine model of acute myocardial infarction. J Am Heart Assoc. 2016 Jul 6;5(7). pii: e003714. doi: 10.1161/JAHA.116.003714
  22. Li H, Liu D, Li C, Zhou S, Tian D, Xiao D, Zhang H, Gao F, Huang J. Exosomes secreted from mutant-HIF-1α-modified bone-marrow-derived mesenchymal stem cells attenuate early steroid-induced avascular necrosis of femoral head in rabbit. Cell Biol Int. 2017 Dec;41(12):1379-90. doi: 10.1002/cbin.10869
Address for correspondence:
630090, The Russian Federation,
Novosibirsk, Ac. Lavrentyev Ave., 8,
Institute of Chemical Biology
and Fundamental Medicine SB RAS,
Center of New Medical Technologies.
Tel.: 8-913-753-0767,
Igor V. Maiborodin
Information about the authors:
Maiborodin Igor V., MD, Professor, Chief Researcher of the Stem Cell Laboratory, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Branch, Novosibirsk, Russian Federation.
Shevela Andrey I., MD, Professor, Head of the Center of Innovative Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Branch, Novosibirsk, Russian Federation.
Morozov Vitaly V., Head of the Laboratory of Invasive Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Branch, Novosibirsk, Russian Federation.
Mikheeva Tatiana V., PhD, Applicant for Doctors Degree of the Stem Cell Laboratory, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Branch, Novosibirsk, Russian Federation.
Figurenko Nikolay F., PhD, Applicant for Doctors Degree of the Stem Cell Laboratory, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Branch, Novosibirsk, Russian Federation.
Maslov Roman V., PhD, Applicant for Doctors Degree of the Stem Cell Laboratory, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Branch, Novosibirsk, Russian Federation.
Maiborodina Vitalina I., MD, Leading Researcher of the Laboratory of Ultrastructural Basis of Pathology, Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, Novosibirsk, Russian Federation.



Danylo Halytsky Lviv National Medical University, Lviv,

The growth of the level of traumatism and the prevalence of orthopedic pathology determine the necessity to advance diagnostics and treatment of injuries and diseases of the musculoskeletal system as a priority trend in the development of health care. Improvement of diagnostic capabilities of modern methods of visualizing conditions of bones, joints and soft tissues, expansion of the scope of high-tech minimally invasive osteosynthesis techniques will change the concept for implementation of orthopedic trauma care.
The proposed literature review is dedicated to the urgency of the problem and analysis of the structure of traumatic injuries, as well as the fundamental advantages of their treatment by the method of intraosseous osteosynthesis, which, due to the closed reposition of fragments and low surgical access outside the damage zone, doesnt cause any additional injury to the tissues in the fracture zone.
The main errors of surgeons when performing intramedullary blocking osteosynthesis have been studied and analyzed. It has been shown that treatment of patients with diaphyseal multi-fragment fractures of the long tubular bones should include measures to restore the anatomical structures of the injured segment and the function of the injured limb. The determination of clear indications and consistent preoperative planning of surgical intervention with careful selection of parameters of fixing structures are the main factors affecting the quality of fixation of fragments and they ensure the final result.

Keywords: trauma, bone fractures, intramedullary osteosynthesis, surgical errors, complications
p. 204-2011 of the original issue
  1. Gaiko GV, Derkach RV. Cause analysis and study of the reasons that influence the mortality rate in a car accident victims with the injuries to the musculoskeletal system. Nauka Praktika. 2014;(1):82-86. (in Ukr.)
  2. Gur’v SO, Satsik SP, vdoshenko VP, Natsevich RO. Lkuvannia perelomv dovgikh kstok u postrazhdalikh unasldok dorozhn’o-transportnikh prigod. Travma. 2015;16(3):94-97. (in Ukr.)
  3. Lacombe J, Cairns BJ, Green J, Reeves GK, Beral V, Armstrong MEG. Million women study collaborators. The effects of age, adiposity, and physical activity on the risk of seven site-specific fractures in postmenopausal women. J Bone Miner Res. 2016 Aug;31(8):1559-68. doi: 10.1002/jbmr.2826
  4. Scholes S, Panesar S, Shelton NJ, Francis RM, Mirza S, Mindell JS, Donaldson LJ. Epidemiology of lifetime fracture prevalence in England: a population study of adults aged 55 years and over. Age and Ageing. 2014;43(2):234-40. doi: 10.1093/ageing/aft167
  5. Zarutsky J, Trutiak I, Laksha A. Surgical tactics in injuries of the locomotor apparatus in patients with multiple injuries. Ltopis Travmatolog ta Ortoped. 2011;(1-2):98-101. (in Ukr.)
  6. Global Burden of Disease [Electronic resource]. WHO. [cited 2018 Dec 29]. Available from:
  7. Grygorieva NV, Zubach OB. Risk factors of proximal hip fractures in older patients. Travma. 2016;17(6):53-61. doi: 10.22141/1608-1706.6.17.2016.88618 (in Ukr.)
  8. Korzh NA, Gerasimenko SI, Klimovitskii VG, Loskutov AE, Romanenko KK, Gerasimenko AS, Kolomiets EN. Rasprostranennost’ perelomov kostei i rezul’taty ikh lecheniia v Ukraine (kliniko-epidemiologicheskoe issledovanie). Ortopediia, Travmatologiia i Protezirovanie. 2010;(3):5-14. (in Ukr.)
  9. Hettrich CM, Browner B. High-energy trauma. Best Pract Res Clin Rheumatol. 2012 Apr;26(2):281-88. doi: 10.1016/j.berh.2012.03.007
  10. Borzykh AV, Klimovitsky VG, Oprischenko AA, Borzykh NA, Basiy RV. Epidemiology of polystructural trauma of the extremities in the Donbass region. Travma. 2013;14(6):61-63. (in Russ.)
  11. Benirschke SK, elder I, Henley MB, Routt ML, Smith DG, Chapman JR, Swiontkowski MF. Closed interlocking nailing of femoral shaft fractures: assessment of technical complcations and functional outcomes by comparison of a prospective database with retrospective review. J Ortop Trauma. 1993;7(2):118-22.
  12. Chan R, Taylor BC, Gentile J. Optimal Management of High-Energy Pilon Fractures. Orthopedics. 2015 Aug;38(8):e708-14. doi: 10.3928/01477447-20150804-59
  13. Ditillo M, Pandit V, Rhee P, Aziz H, Hadeed S, Bhattacharya B, Friese RS, Davis K, Joseph B. Morbid obesity predisposes trauma patients to worse outcomes: a National Trauma Data Bank analysis. J Trauma Acute Care Surg. 2014 Jan;76(1):176-79. doi: 10.1097/TA.0b013e3182ab0d7c
  14. Korzh MO, Tan’kut VO. Medichn aspekti dorozhn’o-transportno pol travmi, iak osnovno prichini smertnost molodikh liudei v Ukran [Electronic resource]. [cited 2018 Dec 29]. Avialable from: (in Ukr.)
  15. Korzh MO, Iaremenko DO, Gordova LD, Romanenko KK. Pomilki ta uskladnennia v ortopedo-travmatologchni praktits. Ortopediia, Travmatologiia i Protezirovanie. 2010;(2):5-10. (in Ukr.)
  16. Zarutskyi YL, Kosevtsov VO, Tkachenko AE. Traumatism in the system of threats to the ukrainian national security. Nauka Praktika. 2014;(1):50-56. Ukr.)
  17. Vallier HA, Wang X, Moore TA, Wilber JH, Como JJ. Timing of orthopaedic surgery in multiple trauma patients: development of a protocol for early appropriate care. J Orthop Trauma. 2013 Oct;27(10):543-51. doi: 10.1097/BOT.0b013e31829efda1
  18. Faddeev DI. Oslozhneniia pri lechenii mnozhestvennykh i sochetannykh perelomov dlinnykh trubchastykh kostei metodami rannego stabil’nogo pogruzhnogo i chreskostnogo osteosinteza. Vestn Travmatologii i Ortopedii. 2013;(1):18-23 (in Russ.)
  19. Brodauf L, Heßing K, Hoffmann R, Friemert B. Current state of medical care of polytrauma and mass casualty ncidents in Germany: are we well-prepared? Unfallchirurg. 2015 Sep 1;118(10):890-900. doi: 10.1007/s00113-015-0063-2
  20. Gur’ev SE, Tsviakh AI. Skeletnaia travma v strukture politravmy. Travma. 2014;15(6):7-10. (in Russ.)
  21. Malisano LP, Stevens D, Hunter GA. The management of long bone fractures in the head-injured polytrauma patient. J Orthop Trauma. 1994;8(1):1-5.
  22. Shimon VM, Sheregi AA, Geleta MM, Boldizhar MM. Pogliadi na lkuvannia perelomv kstok gomlki metodom cherezkstkovogo osteosintezu v umovakh endemchnikh regonv. Ltopis Travmatolog ta Ortoped. 2011;(21-22):180-82. (in Ukr.)
  23. Shimon VM, Sheregi AA. Perspektivn napriamki lkuvannia dafzarnikh perelomv kstok gomlki. Travma. 2010;11(4):363-66. (in Ukr.)
  24. Brusko AT, Gaiko GV. Modern concepts of stages of bone tissue fractures reparative regeneration. Vsnik Ortoped, Travmatolog. 2014;(2):5-8. (in Ukr.)
  25. Klimovitskii VG, Chernysh VIu. Chastota zamedlennoi konsolidatsii perelomov u postradavshikh raznykh vozrastnykh grupp i vliianie na nee osteotropnoi terapii. Travma. 2011;12(3):129-35. (in Russ.)
  26. Anuar-Ramdhan IM, Azahari IM, Med M. Minimally invasive plate osteosynthesis with conventional compression plate for diaphyseal tibia fracture. Malays Orthop J. 2014;8(3):33-36. doi: 10.5704/MOJ.1411.008
  27. Maru N, Mandaliya D, Parmar R. Two stage reconstruction protocol in management of high-energy proximal tibia fractures (Schatzker, type IV-VI). J Evol Med Dent Sci. 2012;1(4):639-45. doi: 10.14260/jemds/100
  28. Butcher NE, Enninghorst N, Sisak K, Balogh ZJ. Definition of polytrauma: variable interrater versus intrarater agreement – a prospective international study among trauma surgeons. J Trauma Acute Care Surg. 2013;74(3):884-89. doi: 10.1097/TA.0b013e31827e1bad.
  29. Champion HR, Copes WS, Sacco WJ, Lawnick MM, Bain LW, Gann DS, Gennarelli T, Mackenzie E, Schwaitzberg S. A new characterization of injury severity. J Trauma. 1990 May;30(5):539-45.
  30. Hoegel FW, Hoffmann S, Weninger P, Bühren V, Augat P. Biomechanical comparison of locked plate osteosynthesis, reamed and unreamed nailing in conventional interlocking technique, and unreamed angle stable nailing in distal tibia fractures. J Trauma Acute Care Surg. 2012 Oct;73(4):933-38. doi: 10.1097/TA.0b013e318251683f
  31. Kalashnikov AV, Stavinsky YuA. Treatment algorithm for reparative osteogenesis disorders after femoral and tibia diaphyseal fractures with blocking intramedullary osteosynthesis. Travma. 2011;12(1):69-66. (in Ukr.)
  32. Henderson CE, Lujan TJ, Kuhl LL, Bottlang M, Fitzpatrick DC, Marsh JL. 2010 mid-America Orthopaedic Association Physician in Training Award: healing complications are common after locked plating for distal femur fractures. Clin Orthop Relat Res. 2011 Jun;469(6):1757-65. doi: 10.1007/s11999-011-1870-6
  33. Pankov IO, Safarov RR, Sirazitdinov SD. Modern method of the surgical treatment of patient with polyfractures of extremyties. Sovrem Problemy Nauki i Obrazovaniia. 2015;(5):243. (in Russ.)
  34. Paller DJ, Frenzen SW, Bartlett CS 3rd, Beardsley CL, Beynnon BD. A three-dimensional comparison of intramedullary nail constructs for osteopenic supracondylar femur fractures. J Orthop Trauma. 2013 Feb;27(2):93-99. doi: 10.1097/BOT.0b013e31825199c9
  35. Lee YK, Chung CY, Park MS, Lee KM, Koo KH. Intramedullary nail versus extramedullary plate fixation for unstable intertrochanteric fractures: decision analysis. Arch Orthop Trauma Surg. 2013 Jul;133(7):961-68. doi: 10.1007/s00402-013-1764-z
  36. Kreb DL, Blokhuis TJ, van Wessem KJ, Bemelman M, Lansink KW, Leenen LP. Intramedullary nailing without interlocking screws for femoral and tibial shaft fractures. Arch Orthop Trauma Surg. 2013 Aug;133(8):1109-13. doi: 10.1007/s00402-013-1775-9
  37. Sokolov VA, Bondarenko AV, Byalik EI, Fain AM, Ivanov PA. Comparative assessment of osteosynthesis techniques in polysegmental fractures of lower extremities. Vestn Travmatologii i Ortopedii im NN Priorova. 2006;(4):3-8. (in Russ.)
  38. Dergachov VV, Aleksandrov N, Vankhaisky SB, Onatsky YuV, Kotenko RS, Kolesnikov AM. Locking intramedullary nailing-modern method, new difficulties, complications .Travma. 2011;12(4):20-23. (in Ukr.)
  39. Berezka MI, Litovchenko VO, Garyachiy VO, Rami AF, Al-Masri. Surgical technology for closed intramedullary osteosynthesis during the treatment of patients with multifragmental fractures of limb bones. Problemi Ekolog ta Meditsini. 2011;15(5-6):3-8. (in Ukr.)
  40. Pven’ IuM, Litvin IuP. Peredoperatsine planuvannia ta vibr metodu osteosintezu pri bagatofragmentarnikh perelomakh proksimal’nogo vddlu plechovo kstki. Problemi Travmatolog ta Osteosintezu. 2015;(1):75-76. (in Ukr.)
  41. Litovchenko VO, Vlasenko DV, Vlasenko VG, Jaryachiy EV, Galabuts,ka TM, Fadev OG. nrameduliarnii osteosintez blokovanimi tsviakhami v lkuvann perelomv stegnovo kstki v rznikh anatomo-funktsonal’nikh utvorenniakh pri odnochasnomu poshkodzhenn. Travma. 2011;12(4):63-66. (in Ukr.)
  42. Chelnokov AN, Bekreyev DA. Intramedullary osteosynthesis for fractures of the upper tibial third - a technique based on transosseous osteosynthesis Genii Ortopedii. 2011;(2):112-16. (in Russ.)
  43. Litovchenko VO, Berezka MI, Garyachiy EV, Rami AF, Al Masri, Vlasenko DV. Mistakes during treatment of multi-fragment fractures of limbs’ bones by implementation of intramedullar blocking ostheosynthesis. Eksperimental’na Klnchna Meditsina. 2012; 4(57):132-135. (in Russ.)
  44. Litovchenko VA, Garyachiy EV, Berezka MI, Spesiviy II. Intramedullary locking osteosynthesis: errors which should not be. Meditsina S’ogodn Zavtra. 2012;(1):113-19. (in Ukr.)
  45. Lytovchenko VA, Jaryachiy YeV, Berezka MI, Spesiviy II. Most common mistakes while using locked intramedullary nailing. Travma. 2012;13(4):145-48. (in Ukr.)
  46. Klimovitsky VH, Chernysh VYu, Klimovitsky FV. External transosseous osteosynthesis in treatment of tibia extraarticular fracture: indications, complications, results. Travma. 2016;17(2):26-30. (in Russ.)
  47. Rusyn VI, Popovych YM, Korsak VV, Boldizhar PO. Radioisotope diagnosis deep venous thrombosis. Naukovii Vsnik Uzhgorods’kogo Unversitetu. Ser Meditsina. 2013;1(46):114-17. (in Ukr.)
Address for correspondence:
79010, Ukraine,
Lviv, Pekarskaya Str., 69,
Danylo Halytsky Lviv National
Medical University,
Department of Disaster Medicine
And Military Medicine.
Tel. +38 (032) 260-08-28,
Viktor S. Kozopas
Information about the authors:
Kozopas Viktor S., PhD, Assistant of the Department of Disaster Medicine and Military Medicine, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.



Vitebsk State Medical University, Vitebsk,
The Republic of Belarus

The scientific literature analysis has shown that researchers in the field of regenerative medicine consider pericytes to be a promising therapeutic target. However, there are still too many problems that require thorough investigations. One of the main tasks is the identification of pericytes. Despite numerous attempts, the molecular marker panel remains undeveloped. All markers which are used to identify pericytes are dynamic in their expression. This may be related to the stages of pericyte differentiation, peculiarities of the tissue structure, the pathological state, the hierarchy of the vessels and the stage of their development. The identification of the source of pericyte development and understanding of the processes governing their differentiation remain the problem of current interest. The mechanism of pericyte differentiation into myofibroblasts, osteoblasts, adipocytes, chondrocytes, smooth myocytes and macrophages remains insufficiently studied and debatable. There is no consensus about pericyte heterogeneity. This is the subject of further research aimed at proving pericyte heterogeneity in terms of morphology and function along the blood vessels; quantitative determination of differences in the expression of markers in different pericyte subtypes and the development of the nomenclature. The determination of phenotypic differences between pericytes during angiogenesis and in mature vessels is of particular interest. This is necessary to understand the functions of pericytes in the microvasculature. An important direction is the detailed study of signaling pathways involved in the regulation of complex interactions between pericytes and endothelial cells. This will not only expand the understanding of the pathogenesis, but also will allow introducing new methods of treatment into practical medicine.

Keywords: pericytes, morphology, origin, markers, signaling pathways, role in pathological processes
p. 212-221 of the original issue
  1. Armulik A, Genov G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 2011 Aug;21(2):193-15. doi: 10.1016/j.devcel.2011.07.001
  2. Berthiaume AA, Hartmann DA, Majesky MW, Bhat NR, Shih AY. Pericyte structural remodeling in cerebrovascular health and homeostasis. Front Aging Neurosci. 2018 Jul;10:210. doi: 10.3389/fnagi.2018.00210
  3. Hartmann DA, Underly RG, Grant RI, Watson AN, Lindner V, Shih AY. Pericyte structure and distribution in the cerebral cortex revealed by high-resolution imaging of transgenic mice. Neurophotonics. 2015 Oct;2(4):041402. doi: 10.1117/1.NPh.2.4.041402
  4. Klein D. The tumor vascular endothelium as decision maker in cancer therapy. Front Oncol. 2018 Sep;8:367. doi: 10.3389/fonc.2018.00367
  5. Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Volarevic V. Molecular mechanisms underlying therapeutic potential of pericytes. J Biomed Sci. 2018 Mar 9;25(1):21. doi: 10.1186/s12929-018-0423-7
  6. Thomas HM, Cowin AJ, Mills1 SJ. The importance of pericytes in healing: wounds and other pathologies. Int J Mol Sci. 2017 Jun;18(6):1129. Published online 2017 May 24. doi: 10.3390/ijms18061129
  7. Feng J, Mantesso A, De Bari C, Nishiyama A, Sharpe PT. Dual origin of mesenchymal stem cells contributing to organ growth and repair. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6503-8. doi: 10.1073/pnas.1015449108
  8. Orekhov AN, Bobryshev YV, Chistiakov DA. The complexity of cell composition of the intima of large arteries: focus on pericyte-like cells. Cardiovasc Res. 2014 Sep 1;103(4):438-51. doi: 10.1093/cvr/cvu168
  9. Mao Y, Liu X, Song Y, Zhai C, Zhang L. VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis. PLoS One. 2018 Aug 20;13(8):e0201395. doi: 10.1371/journal.pone.0201395
  10. Schrimpf C, Koppen T, Duffield JS, Ber U, David S, Ziegler W, Haverich A, Teebken OE, Wilhelmi M. TIMP3 is regulated by pericytes upon shear stress detection leading to modified endothelial cell response. Eur J Vasc Endovasc Surg. 2017 Oct;54(4):524-33. doi: 10.1016/j.ejvs.2017.07.002
  11. Murray IR, Baily JE, Chen WCW, Dar A, Gonzalez ZN, Jensen AR, Petrigliano FA, Deb A, Henderson NC.. Skeletal and cardiac muscle pericytes: functions and therapeutic potential. Pharmacol Ther. 2017 Mar;171:65-74. doi: 10.1016/j.pharmthera.2016.09.005
  12. Kumar A, D’Souza SS, Moskvin OV, Toh H, Wang B, Zhang J, Swanson S, Guo LW, Thomson JA, Slukvin II. Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts. Cell Rep. 2017 May 30;19(9):1902-16. doi: 10.1016/j
  13. Chen Q, Zhang H, Liu Y, Adams S, Eilken H, Stehling M, Corada M, Dejana E, Zhou B, Adams RH. Endothelial cells are progenitors of cardiac pericytes and vascular smoothmuscle cells. Nat Commun. 2016 Aug 12;7:12422. doi: 10.1038/ncomms12422
  14. Díaz-Flores L, Gutirrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martín-Vasallo P, Díaz-Flores LJr. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol. 2009 Jul;24(7):909-69. doi: 10.14670/HH-24.909
  15. Navarro P, Ruco L, Dejana E. Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol. 1998 Mar 23;140(6):1475-84. doi: 10.1083/jcb.140.6.1475
  16. Ivanova EA, Orekhov AN. Cellular model of atherogenesis based on pluripotent vascular wall pericytes. Stem Cells Int. 2016;2016:7321404. doi: 10.1155/2016/7321404
  17. Crislip GR, O’Connor PM, Wei Q, Sullivan JC. Vasa recta pericyte density is negatively associated with vascular congestion in the renal medulla following ischemia reperfusion in rats. Am J Physiol Renal Physiol. 2017 Nov 1;313(5): F1097-F1105. doi: 10.1152/ajprenal.00261.2017
  18. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest. 2010 Jan;120(1):11-19. doi: 10.1172/JCI40373
  19. Goodall EF, Wang C, Simpson JE, Baker DJ, Drew DR, Heath PR, Saffrey MJ, Romero IA, Wharton SB. Age-associated changes in the blood-brain barrier: comparative studies in human and mouse. Neuropathol Appl Neurobiol. 2018 Apr;44(3):328-40. doi: 10.1111/nan.12408
  20. Chung YR, Choi JA, Koh JY, Yoon YH. Ursodeoxycholic acid attenuates endoplasmic reticulum stress-related retinal pericyte loss in streptozotocin-induced diabetic mice. J Diabetes Res. 2017;2017:1763292. doi: 10.1155/2017/1763292
  21. Yamazaki T, Mukouyama YS. Tissue specific origin, development, and pathological perspectives of pericytes. Front Cardiovasc Med. 2018 Jun 27;5:78. doi: 10.3389/fcvm.2018.00078
  22. Birbrair A, Borges IDT, Gilson Sena IF, Almeida GG, da Silva Meirelles L, GonÇalves R, Mintz A, Delbono O. How plastic are pericytes? Stem Cells Dev. 2017 Jul 15;26(14):1013-19. doi: 10.1089/scd.2017.0044
  23. Attwell D, Mishra A, Hall CN, O’Farrell FM, Dalkara T. What is a pericyte? J Cereb Blood Flow Metab. 2016 Feb;36(2):451-55. doi: 10.1177/0271678X15610340
  24. Esteves CL, Donadeu FX. Pericytes and their potential in regenerative medicine across species. Cytometry A. 2018 Jan;93(1):50-59. doi: 10.1002/cyto.a.23243
  25. Tian X, Brookes O, Battaglia G. Pericytes from mesenchymal stem cells as a model for the blood-brain barrier. Sci Rep. 2017 Jan;7:39676. doi: 10.1038/srep39676
  26. Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? Angiogenesis. 2017 May;20(2):185-204. doi: 10.1007/s10456-017-9552-y
  27. Dias Moura Prazeres PH, Sena IFG, Borges IDT, de Azevedo PO, Andreotti JP, de Paiva AE, de Almeida VM, de Paula Guerra DA, Pinheiro Dos Santos GS, Mintz A, Delbono O, Birbrair A. Pericytes are heterogeneous in their origin within the same tissue. Dev Biol. 2017 Jul 1;427(1):6-11. doi: 10.1016/j.ydbio.2017.05.001
  28. Gautam J, Nirwane A, Yao Y. Laminin differentially regulates the stemness of type I and type II pericytes. Stem Cell Res Ther. 2017 Feb 7;8(1):28. doi: 10.1186/s13287-017-0479-4
  29. Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang ZM, Messi ML, Mintz A, Delbono O. Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther. 2014 Nov 6;5(6):122. doi: 10.1186/scrt512
  30. Krishna Priya S, Nagare RP, Sneha VS, Sidhanth C, Bindhya S, Manasa P, Ganesan TS. Tumour angiogenesis-origin of blood vessels. Int J Cancer. 2016 Aug 15;139(4):729-35. doi: 10.1002/ijc.30067
  31. Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Volarevic V. Molecular mechanisms underlying therapeutic potential of pericytes. J Biomed Sci. 2018 Mar 9;25(1):21. doi: 10.1186/s12929-018-0423-7
  32. Onogi Y, Wada T, Kamiya C, Inata K, Matsuzawa T, Inaba Y, Kimura K, Inoue H, Yamamoto S, Ishii Y, Koya D, Tsuneki H, Sasahara M, Sasaoka T. PDGFRβ Regulates Adipose Tissue expansion and glucose metabolism via vascular remodeling in diet-induced obesity. Diabetes. 2017 Apr;66(4):1008-21. doi: 10.2337/db16-0881
  33. Park DY, Lee J, Kim J, Kim K, Hong S, Han S, Kubota Y, Augustin HG, Ding L, Kim JW, Kim H, He Y, Adams RH, Koh GY. Plastic roles of pericytes in the blood-retinal barrier. Nat Commun. 2017 May 16;8:15296. doi: 10.1038/ncomms15296
  34. Kuzmanov A, Hopfer U, Marti P, Meyer-Schaller N, Yilmaz M, Christofori G. LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling. Mol Oncol. 2014 Mar;8(2):401-16. doi: 10.1016/j.molonc.2013.12.009
  35. Kobayashi H, DeBusk LM, Babichev YO, Dumont DJ, Lin PC. Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood. 2006 Aug 15;108(4):1260-66. doi: 10.1182/blood-2005-09-012807
  36. He C, Lv X, Hua G, Lele SM, Remmenga S, Dong J, Davis JS, Wang C. YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression. Oncogene. 2015 Dec 10;34(50):6040-54. doi: 10.1038/onc.2015.52
  37. Miyagawa S, Katsu Y, Watanabe H, Iguchi T. Estrogen-independent activation of erbBs signaling and estrogen receptor alpha in the mouse vagina exposed neonatally to diethylstilbestrol. Oncogene. 2004 Jan 15;23(2):340-49. doi: 10.1038/sj.onc.1207207
  38. Qin G, Chen Y, Li H, Xu S, Li Y, Sun J, Rao W, Chen C, Du M, He K, Ye Y. Melittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model. Mol Med Rep. 2016 Jul;14(1):57-68. doi: 10.3892/mmr.2016.5215
  39. Lee J, Marrero L, Yu L, Dawson LA, Muneoka K, Han M. SDF-1α/CXCR4 signaling mediates digit tip regeneration promoted by BMP-2. Dev Biol. 2013 Oct 1;382(1):98-109. doi: 10.1016/j.ydbio.2013.07.020
  40. Tang F, Guo S, Liao H, Yu P, Wang L, Song X, Chen J, Yang Q. Resveratrol enhances neurite outgrowth and synaptogenesis via sonic hedgehog signaling following oxygen-glucose deprivation/reoxygenation injury. Send to Cell Physiol Biochem. 2017;43(2):852-69. doi: 10.1159/000481611
  41. Yamazaki T, Nalbandian A, Uchida Y, Li W, Arnold TD, Kubota Y, Yamamoto S, Ema M, Mukouyama YS. Tissue myeloid progenitors differentiate into pericytes through TGF-β signaling in developing skin vasculature. Cell Rep. 2017 Mar 21;18(12):2991-04. doi: 10.1016/j
  42. Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016 May 26;19(6):771-83. doi: 10.1038/nn.4288
  43. Lipphardt M, Song JW, Matsumoto K, Dadafarin S, Dihazi H, Müller G, Goligorsky MS. The third path of tubulointerstitial fibrosis: aberrant endothelial secretome. Kidney Int. 2017 Sep;92(3):558-68. doi: 10.1016/j.kint.2017.02.033
  44. Leaf IA, Nakagawa S, Johnson BG, Cha JJ, Mittelsteadt K, Guckian KM, Gomez IG, Altemeier WA, Duffield JS. Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury. J Clin Invest. 2017 Jan 3;127(1):321-34. doi: 10.1172/JCI87532
  45. Jackson S, ElAli A, Virgintino D, Gilbert MR. Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer’s disease. Neuro Oncol. 2017 Sep 1;19(9):1173-82. doi: 10.1093/neuonc/nox058
  46. Schiffer D, Annovazzi L, Casalone C, Corona C, Mellai M. Glioblastoma: microenvironment and niche concept. Cancers (Basel). 2018 Dec 20;11(1). pii: E5. doi: 10.3390/cancers11010005
  47. Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J. 2018 Oct;42(5):364-76. doi: 10.4093/dmj.2018.0182
  48. Wang Y, Xu J, Chang L, Meyers CA, Zhang L, Broderick K, Lee M, Peault B, James AW. Relative contributions of adipose-resident CD146+ pericytes and CD34+ adventitial progenitor cells in bone tissue engineering. NPJ Regen Med. 2019 Jan 7;4:1. doi: 10.1038/s41536-018-0063-2
  49. Panina YA, Yakimov AS, Komleva YK, Morgun AV, Lopatina OL, Malinovskaya NA, Shuvaev AN, Salmin VV, Taranushenko TE, Salmina AB. Plasticity of adipose tissue-derived stem cells and regulation of angiogenesis. Front Physiol. 2018 Nov 26;9:1656. doi: 10.3389/fphys.2018.01656
  50. Lerman DA, Diaz M, Peault B. Changes in coexpression of pericytes and endogenous cardiac progenitor cells from heart development to disease state. Eur Heart J. 2018 Aug 28;39(Suppl 1). pii: P1850. doi: 10.1093/eurheartj/ehy565.P1850
Address for correspondence:
210009, The Republic of Belarus,
Vitebsk, Frunze Ave., 27,
Vitebsk State Medical University,
Department of Histology,
Cytology and Embryology.
Tel. mob.: + 375 33 675 76 99,
Elena I. Lebedeva
Information about the authors:
Sushkou Siarhei A., PhD, Associate Professor, Vice-rector of Scientific and Research Affairs, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
Lebedeva Elena I., PhD, Associate Professor of the Department of Histology, Cytology and Embryology, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
Myadelets Oleg D., MD, Professor, Head of the Department of Histology, Cytology and Embryology, Vitebsk State Medical University, Vitebsk, Republic of Belarus.




I.P. Pavlov Ryazan State Medical University, Ryazan,
The Russian Federation

Aneurysmal bone cyst is a rare benign tumor-like disease, which typically affects metaphyses of long tubular bones. Most often this osteolytic bone neoplasm occurs and is diagnosed in childhood or adolescence with a slight predominance of female subjects. There is no specific clinical manifestation of an aneurysmal bone cyst; its development is characterized by pain syndrome, swelling of soft tissues, restriction of limb function, less frequently - by pathological fractures. Aneurysmal bone cyst as a primary benign rib tumor is extremely rare, especially in the elderly. The article presents a clinical observation of a 69-year-old male patient with an aneurysmal bone cyst of the second left rib. The reason for seeking medical help was the increasing pain in the chest on the side of the lesion. X-ray computed tomography made it possible to determine the exact localization of the neoplasm, its relationship with the ribs and structures of the mediastinum. The cyst was radically removed through left thoracotomy, by excision of the tumor with the cortical layer of the rib. The subsequent morphological study confirmed the diagnosis of the aneurysmal bone cyst. The patient was being observed for 6 months and had no signs of the disease recurrence.

Keywords: solitary bone cyst, aneurysmal bone cyst, rib, benign neoplasm of ribs, rib resection
p. 222-226 of the original issue
  1. Cappana R, Albisinni U, Picci P, Calderoni P, Campanacci M and Spingfield S. Aneurysmal bone cyst of the spine. J Bone Joint Surg Am. 1985;67(4):527-31. doi: 10.2106/00004623-198567040-00004
  2. Guo J, Liang C. A giant aneurysmal bone cyst of the rib: Case report. Oncol Lett. 2014 Jan;7(1):267-29. doi: 10.3892/ol.2013.1642
  3. Jaffe HL, Lichtenstein L. Solitary unicameral bone cyst with emphasis on the roentgen picture, the pathologic appearance and the pathogenesis. Arch Surg. 1942;44(6):1004-25. doi: 10.1001/archsurg.1942.01210240043003
  4. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. 2013;5. 468 .
  5. Rogozhin DV, Konovalov DM, Bolshakov NA, Talalaev AG, Kozlov AS, Kuzin AS. Aneurysmal bone cyst in children and adolescents. Vopr Gematologii/Onkologii i Immunopatologii v Pediatrii. 2017;16(2):33-39. doi: 10.24287/1726-1708-2017-16-2-33-39 (in Russ.)
  6. Bludov AB, Zamogilnaya YaA, Nered AS, Kochergina NV. Aneurysmal bone cyst. Sarkomy Kostei, Miagkikh Tkanei i Opukholi Kozhi. 2013;(4):3-9. (in Russ.)
  7. Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, Gebhardt MC, Rosenberg AE, Fletcher JA. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004 Nov;165(5):1773-80. doi: 10.1016/S0002-9440(10)63432-3
  8. Solovyov AE, Laricheva OV. The results of treatment of bone cysts and bone tumor in children. Ros Med-Biol Vestn im Akad IP Pavlova. 2017;25(2):264-69. doi: 10.23888/PAVLOVJ20172264-269. (in Russ.)
  9. Robinson AE, Thomas RL, Monson DM. Aneurysmal bone cyst of the rib. A report of two unusual cases. Am J Roentgenol Radium Ther Nucl Med. 1967 Jul;100(3):526-29. doi: 10.2214/ajr.100.3.526
  10. Sabanathan S, Chen K, Robertson CS, Salama FD. Aneurysmal bone cyst of rib. Thorax 1984 Feb;39(2):125-30. doi: 10.1136/thx.39.2.125
  11. Çalik M, Çalik SG, Aygün MS, Esme H. Aneurysmal bone cyst of rib: a report of a rare case. J Emerg Med Case Rep. 2016;7:49-50 doi: 10.5152/jemcr.2016.1508
Address for correspondence:
390026, The Russian Federation,
Ryazan, Vysokovoltnaya Str., 9,
I.P. Pavlov Ryazan State Medical University,
Department of Faculty Surgery
With the Course of Anesthesiology
And Resuscitation.
Tel. +7 910 902-18-36,
Alexey V. Mikheev
Information about the authors:
Trushin Sergey N., MD, Professor, Head of the Department of Faculty Surgery with the Course of Anesthesiology and Resuscitation, I.P. Pavlov Ryazan State Medical University, Ryazan, Russian Federation.
Mikheev Alexey V., PhD, Associate Professor of the Department of Faculty Surgery with the Course of Anesthesiology and Resuscitation, I.P. Pavlov Ryazan State Medical University, Ryazan, Russian Federation.



Irkutsk Scientific Center of Surgery and Traumatology, Irkutsk,
The Russian Federation

The article presents a clinical case of successful surgical treatment of the female patient with the combination of two types of toe deformities hallux valgus and 2nd varus hammer toe (overlapping toes). At the examination of the patient we assessed the character and the degree of severity of toe deformity, made necessary calculations and chose optimal surgical methods of treatment. Using original method of surgical treatment allowed us correcting hallux valgus and using Helal method contributed to the correction of 2nd varus hammer toe. This clinical case shows the importance of preoperative planning including precise preliminary calculations and determination of some parameters which are necessary for the correction of toe deformities. Preoperative calculation of such parameters as length of necessary shortening and value of necessary lateral shift of the instep bone fragment makes it possible to perform precise marking of the lines on the instep bone fragment which helps restoring its anatomy and statodynamic function without any recurrence in the postoperative period.

Keywords: hallux valgus, hammer toe syndrome, foot deformity, toe, overlapping toes, parameters of necessary shortening and shift
p. 227-231 of the original issue
  1. Kondrashova IA, Davletova NA, Kondrashov AN. Clinicoradiological aspects for diagnosis of hallux valgus and metatarsus latus. Travma 2013;14(4): 81-86. (in Russ.)
  2. Shi GG, Henning P, Marks RM. Correlation of postoperative position of the sesamoids after Chevron osteotomy with outcome. Foot Ankle Int. 2016;37(3):274-80. doi: 10.1177/1071100715624147
  3. Sorokin EP, Kardanov AA, Lasunskiy SA, Bezgodkov YA. Gudz AI. Surgical treatment of hallux valgus and its possible complications (review). Traumatology and Orthopedics of Russia. 2011;(4):123-30. doi: 10.21823/2311-2905-2011--4-123-130 (In Russ.)
  4. Kardanov AA. Khirurgicheskaia korrektsiia deformatsii stopy. Moscow, RF: Medpraktika-M; 2016. 220 s. (in Russ.)
  5. Trnka HJ, Mühlbauer M, Zettl R, Myerson MS, Ritschl P. Comparison of the results of the Weil and Helal osteotomies for the treatment of metatarsalgia secondary to dislocation of the lesser metatarsophalangeal joints. Foot Ankle Int. 1999 Feb;20(2):72-79. doi: 10.1177/107110079902000202
Address for correspondence:
664003, The Russian Federation,
Irkutsk, Bortsov Revoliusii Str., 1,
Irkutsk Scientific Center of Surgery and Traumatology,
Research and Clinical Traumatology Department.
Tel. +7 9641142814,
Ivan V. Usoltsev
Information about the authors:
Leonova Svetlana N., MD, Leading Researcher of the Research and Clinical Traumatology Department, Irkutsk Scientific Center of Surgery and Traumatology, Irkutsk, Russian Federation.
Usoltsev Ivan V., Researcher of the Research and Clinical Traumatology Department, Irkutsk Scientific Center of Surgery and Traumatology, Irkutsk, Russian Federation.





p. 232-239 of the original issue
Contacts | ©Vitebsk State Medical University, 2007-2023